GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3676 - 3700 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G07483YN
343
IgG Patient 2 3 mild
G07483YN
35
IgM Patient 2 3 mild
G07483YN
126
IgA Patient 3 -180 mild
G07483YN
269
IgA Patient 3 11 mild
G07483YN
397
IgG Patient 3 -180 mild
G07483YN
54
IgG Patient 3 11 mild
G07483YN
42
IgM Patient 3 -180 mild
G07483YN
102
IgA Patient 3 4 mild
G07483YN
435
IgG Patient 3 4 mild
G07483YN
38
IgM Patient 3 11 mild
G07483YN
116
IgM Patient 3 4 mild
G07483YN
106
IgA Patient 4 12 mild
G07483YN
359
IgG Patient 4 12 mild
G07483YN
94
IgM Patient 4 12 mild
G07483YN
196
IgA Patient 1 10 moderate
G03499BP
391
IgA Patient 1 22 moderate
G03499BP
343
IgA Patient 1 6 moderate
G03499BP
378
IgG Patient 1 10 moderate
G03499BP
32
IgG Patient 1 22 moderate
G03499BP
36
IgG Patient 1 6 moderate
G03499BP
36
IgM Patient 1 10 moderate
G03499BP
60
IgM Patient 1 22 moderate
G03499BP
73
IgM Patient 1 6 moderate
G03499BP
61
IgA Patient 2 15 mild
G03499BP
308

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024